资源 » 参考数据库 » 客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor D-1-methyl-tryptophan.

J Hematol Oncol. 2017;

Zhang Xiaolong，Yang Yuanyuan，Zhang Leisheng，Lu Yang，Zhang Qing，Fan Dongmei，Zhang Yizhi，Zhang Yanjun，Ye Zhou，Xiong Dongs

Products/Services Used	Details	Operation
Recombinant Proteins	(GenScript, USA) and were used for cell-binding assays and cytotoxicity assays in vitro. In addition	Get A Quote

摘要

Although blinatumomab， a bispecific T cell engaging antibody， exhibits high clinical response rates in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (B-ALL) and B cell non-Hodgkin's lymphoma (B-NHL)， it still has some limitations because of its short half-life. Mesenchymal stromal cells (MSCs) represent an attractive approach for delivery of therapeutic agents to cancer sites owing to their tropism towards tumors， but their immunosuppression capabilities， especially induced by indoleamine 2，3-dioxygenase (IDO)， should also be taken into consideration.